Charles Pitman CFA
Stock Analyst at Barclays
(4.64)
# 864
Out of 4,651 analysts
370
Total ratings
67.7%
Success rate
15.5%
Average return
Main Sectors:
Stocks Rated by Charles Pitman CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: PPGN PolyPeptide Group AG | Downgraded: Hold | CHF 40.00 → CHF 44.31 | CHF 44.10 | +0.48% | 7 | Aug 14, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Hold | €135.00 → €140.00 | €136.30 | +2.71% | 20 | Aug 7, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 670.00 → CHF 680.00 | CHF 562.60 | +20.87% | 31 | Aug 7, 2026 | |
| LON: 0NZT UCB SA | Maintained: Hold | €300.00 → €260.00 | €215.55 | +20.62% | 132 | Aug 3, 2026 | |
| BIT: REC Recordati Industria Chimica e Farmaceutica S.p.A. | Reiterated: Hold | €48.00 → €50.00 | €52.50 | -4.76% | 16 | Jul 30, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €50.00 → €60.00 | €47.79 | +25.55% | 17 | Jul 14, 2026 | |
| EPA: BIM bioMérieux S.A. | Maintained: Hold | €90.00 → €80.00 | €73.10 | +9.44% | 6 | Jun 23, 2026 | |
| SWX: BANB Bachem Holding AG | Maintained: Hold | CHF 65.00 → CHF 70.00 | CHF 75.25 | -6.98% | 12 | Jun 9, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €270.00 | €237.50 | +13.68% | 22 | Apr 23, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €220.00 | €185.50 | +18.60% | 17 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €13.50 → €12.50 | €9.86 | +26.77% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 75.00 | CHF 73.00 | +2.74% | 1 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $13.84 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $520.00 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | €105.00 → €60.00 | €74.42 | -19.38% | 3 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €700.00 → €850.00 | €730.50 | +16.36% | 26 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €120.00 → €125.00 | €156.00 | -19.87% | 30 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $671 → $752 | $851.29 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $21 | $7.78 | n/a | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $249.46 | n/a | 1 | Jan 13, 2022 |
PolyPeptide Group AG
Aug 14, 2026
Downgraded: Hold
Price Target: CHF 40.00 → CHF 44.31
Current: CHF 44.10
Upside: +0.48%
Merck KGaA
Aug 7, 2026
Reiterated: Hold
Price Target: €135.00 → €140.00
Current: €136.30
Upside: +2.71%
Lonza Group AG
Aug 7, 2026
Maintained: Buy
Price Target: CHF 670.00 → CHF 680.00
Current: CHF 562.60
Upside: +20.87%
UCB SA
Aug 3, 2026
Maintained: Hold
Price Target: €300.00 → €260.00
Current: €215.55
Upside: +20.62%
Recordati Industria Chimica e Farmaceutica S.p.A.
Jul 30, 2026
Reiterated: Hold
Price Target: €48.00 → €50.00
Current: €52.50
Upside: -4.76%
Bayer Aktiengesellschaft
Jul 14, 2026
Maintained: Buy
Price Target: €50.00 → €60.00
Current: €47.79
Upside: +25.55%
bioMérieux S.A.
Jun 23, 2026
Maintained: Hold
Price Target: €90.00 → €80.00
Current: €73.10
Upside: +9.44%
Bachem Holding AG
Jun 9, 2026
Maintained: Hold
Price Target: CHF 65.00 → CHF 70.00
Current: CHF 75.25
Upside: -6.98%
Sartorius Aktiengesellschaft
Apr 23, 2026
Maintained: Buy
Price Target: €270.00
Current: €237.50
Upside: +13.68%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €220.00
Current: €185.50
Upside: +18.60%
Apr 22, 2026
Maintained: Buy
Price Target: €13.50 → €12.50
Current: €9.86
Upside: +26.77%
Mar 11, 2026
Maintained: Hold
Price Target: CHF 75.00
Current: CHF 73.00
Upside: +2.74%
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $13.84
Upside: -
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $520.00
Upside: -
Jan 6, 2026
Downgraded: Sell
Price Target: €105.00 → €60.00
Current: €74.42
Upside: -19.38%
Oct 31, 2025
Maintained: Buy
Price Target: €700.00 → €850.00
Current: €730.50
Upside: +16.36%
Oct 24, 2025
Maintained: Hold
Price Target: €120.00 → €125.00
Current: €156.00
Upside: -19.87%
Apr 28, 2025
Maintained: Buy
Price Target: $671 → $752
Current: $851.29
Upside: n/a
Jan 4, 2024
Upgraded: Buy
Price Target: $21
Current: $7.78
Upside: n/a
Jan 13, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $249.46
Upside: n/a